<DOC>
	<DOCNO>NCT00005979</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . It yet know combination chemotherapy effective without irinotecan treat colon cancer . PURPOSE : Randomized phase III trial compare effectiveness combination chemotherapy without irinotecan treating patient stage III colon cancer .</brief_summary>
	<brief_title>Combination Chemotherapy With Without Irinotecan Treating Patients With Stage III Colon Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare effect leucovorin calcium fluorouracil without irinotecan 3 year survival rate overall survival patient resect node positive colon cancer high risk recurrence . - Compare toxicity regimens patient . - Compare quality life patient . OUTLINE : This randomize , multicenter study . Patients stratify accord center , disease type ( occlusion v perforation v N2 ) , delay surgery chemotherapy ( 28 day less vs 28 day ) , age ( 65 vs 65 ) . Patients randomize one two treatment arm . - Arm I : Patients receive leucovorin calcium IV 2 hour fluorouracil IV 22 hour day 1 2 . - Arm II : Patients receive irinotecan IV 90 minute day 1 follow leucovorin calcium fluorouracil arm I . Treatment repeat every 14 day 12 course absence disease progression unacceptable toxicity . Quality life assess treatment , 6 12 course , 1 year . Patients follow every 3 month 2 year , every 6 month 3 year . PROJECTED ACCRUAL : A total 400 patient ( 200 per arm ) accrue study within 3 year .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven stage III adenocarcinoma colon curatively resect within past 42 day No metastatic disease Node positive No 4 node affect ( Tx , N2 , M0 ) AND/OR N1 N2 perforation and/or occlusion No prior rectal cancer within 10 cm anal margin treat preoperative radiotherapy No prior inflammatory disease intestine PATIENT CHARACTERISTICS : Age : 18 75 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Neutrophil count least 2,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin le 1.25 time upper limit normal ( ULN ) SGOT SGPT less 3 time ULN Alkaline phosphatase less 3 time ULN Renal : Not specify Cardiovascular : No myocardial infarction within past 6 month No insufficient cardiac function Other : No serious medical illness No active infection No malignancy except skin cancer carcinoma situ cervix No psychological social condition would preclude study Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics Surgery : See Disease Characteristics No prior extensive intestinal resection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2000</verification_date>
	<keyword>stage III colon cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
</DOC>